# InVivium Capital

InVivium Capital is a Private Equity based in Chicago, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Chicago, United States
- **Region:** North America
- **Address:** Stamford, CT, United States
- **Assets under management:** Undisclosed
- **Website:** www.invivium.com
- **LinkedIn:** https://linkedin.com/company/invivium-capital

## Regulatory record

- **CRD number:** 328170
- **SEC file number:** 802-128943
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/328170

## About

InVivium Capital is a venture capital fund focused on investments in healthcare and life sciences. The firm seeks transformative solutions that provide a step-change in value to patients, payers, and providers as well as pharma, biotech and med tech. It invests across the spectrum of innovation in healthcare, primarily focusing on biotechnology and medical device. Its mission is to work side by side with phenomenal people to bring transformational technologies to life.

## Offices

- Chicago, IL
- New York, NY

## People

- Michael Liang — Ph.D., Managing Partner
- Amy Len Kobe — Partner
- Christopher Cox — Partner
- Alyse Passaglia — Vice President of HR & Operations
- Shahryar Oveissi — Operating Partner
- Christine Neipert — J.D., Ph.D., IP Advisor

## Questions

### Where does InVivium Capital's capital come from?

The firm has not disclosed its funding sources, limited partner composition, or committed capital base. For firms operating across multiple offices with a seed-to-growth mandate, typical LP profiles include family offices, endowments, fund-of-funds, and high-net-worth individuals — but InVivium's specific capital stack cannot be confirmed from the public record.

### Does InVivium Capital manage commingled funds or invest deal-by-deal?

InVivium has not disclosed whether it operates through a traditional commingled fund structure, special purpose vehicles, or a deal-by-deal syndication model. The firm's private equity designation and early-to-growth-stage mandate are compatible with any of these structures, but the specific vehicle architecture is not part of the public record.

## Related profiles

- [Invitalia](https://altss.com/profile/invitalia)
- [Invivo Partners](https://altss.com/profile/invivo-partners)

---

Last updated: 2026-08-11T15:07:05.535Z

Canonical page: https://altss.com/profile/invivium-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology